BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31171769)

  • 1. Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma.
    Chen Y; Deng X; Chen W; Shi P; Lian M; Wang H; Wang K; Qian D; Xiao D; Long H
    Cell Death Dis; 2019 Jun; 10(6):448. PubMed ID: 31171769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBM.
    Li W; Miao X; Liu L; Zhang Y; Jin X; Luo X; Gao H; Deng X
    Oncotarget; 2017 Apr; 8(15):25167-25176. PubMed ID: 28445937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma.
    Wang Y; Wang M; Wei W; Han D; Chen X; Hu Q; Yu T; Liu N; You Y; Zhang J
    Oncotarget; 2016 Aug; 7(31):49450-49458. PubMed ID: 27385092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-491 functions as a tumor suppressor through Wnt3a/β-catenin signaling in the development of glioma.
    Meng Y; Shang FR; Zhu YL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10899-10907. PubMed ID: 31858558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma.
    Tian Y; Nan Y; Han L; Zhang A; Wang G; Jia Z; Hao J; Pu P; Zhong Y; Kang C
    Int J Oncol; 2012 Apr; 40(4):1105-12. PubMed ID: 22179124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
    Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
    Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
    Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-16 suppresses epithelial-mesenchymal transition‑related gene expression in human glioma.
    Wang Q; Li X; Zhu Y; Yang P
    Mol Med Rep; 2014 Dec; 10(6):3310-4. PubMed ID: 25242314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1.
    Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J
    Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
    Zhang P; Chen FZ; Jia QB; Hu DF
    IUBMB Life; 2019 Dec; 71(12):1857-1875. PubMed ID: 31381269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-497/Wnt3a/c-jun feedback loop regulates growth and epithelial-to-mesenchymal transition phenotype in glioma cells.
    Lu F; Ye Y; Zhang H; He X; Sun X; Yao C; Mao H; He X; Qian C; Wang B; Xie L; Xie T; Lu G; Zhang S
    Int J Biol Macromol; 2018 Dec; 120(Pt A):985-991. PubMed ID: 30171955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-451 suppresses EMT and metastasis in glioma cells.
    Nan Y; Guo L; Lu Y; Guo G; Hong R; Zhao L; Wang L; Ren B; Yu K; Zhong Y; Huang Q
    Cell Cycle; 2021 Jul; 20(13):1270-1278. PubMed ID: 34048322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7.
    Yue X; Cao D; Lan F; Pan Q; Xia T; Yu H
    Neuro Oncol; 2016 Sep; 18(9):1288-96. PubMed ID: 27006177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.